Dejean; Anne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dejean; Anne.The latest application filed is for "novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor".

Company Profile

0.4.5

Dejean; Anne - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Identification of a synthetic ligand for retinoic acid receptor beta Grant 7,622,266 - Blaudin de The , et al. November 24, 2	2009-11-24
Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor App 20060189798 - Blaudin de The; Hugues ; et al.	2006-08-24
Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same App 20040076950 - Dejean, Anne ; et al.	2004-04-22
Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor App 20030153740 - Blaudin de The, Hugues ; et al.	2003-08-14
Homozygous deletion of chromosome 8p23 in hepatocellular carcinoma App 20030027155 - DeJean, Anne ; et al.	2003-02-06
Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same Grant 6,410,724 - Dejean , et al. June 25, 2	2002-06-25
Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same App 20020042073 - Dejean, Anne ; et al.	2002-04-11
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor Grant 5,376,530 - De The , et al. December 27, 1	1994-12-27
Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor Grant 5,317,090 - Blaudin De The , et al. May 31, 1	1994-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.